Back
Speaker illustration

undefined undefined undefined

Presentations

Medical education significantly improves the recognition of red flags of transthyretin cardiac amyloidosis

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (3)

Access
Like
Thumbnail

Interactive case-based education significantly improves competence in diagnosing transthyretin cardiac amyloidosis

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

Access
Like
Thumbnail

Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

Access
Like
Thumbnail

Understanding the patient burden in transthyretin cardiac amyloidosis is significantly improved with continuing medical education

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (1)

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources